RE:RE:RE:RE:RE:RE:RE:RE:Resistance at 0.31cents Organigram: SP $4.08
Q1 2021 net revenue of $19.3 million
Q1 2021 negative adjusted EBITDA of $6.4 million
Net loss:Q1 2021 net loss of $34.3 million
Cronos: SP $14.07
Third Quarter 2020
Net revenue of $11.4 million in Q3 2020
Reported operating loss of $41.2 million
Cronos Group (NASDAQ: CRON) has been one of the safer pot stocks to invest in, if for no other reason than it is backed by tobacco giant Altria, which owns a 45% stake in the business. But beyond that, Cronos hasn't given investors much reason to buy in. With relatively low sales numbers and operating losses in each of the past four quarters, its financials aren't all that impressive.
Sundial Growers: SP $1.34 Outstanding shares 1.56 billion
Net loss was $71.4 million in the third quarter; adjusted EBITDA loss increased by 13% over the previous quarter to $4.4 million
Net cannabis revenue for the third quarter of 2020 was $12.9 million
SUPREME SP $.30 with premium product at scale and with outstanding Q2, REALLY!!!!!
I could continue, but anyone stating Supreme is correctly valuated should deep dive in other companies financials. IMHO